Yüklüyor......
Monitoring standard and extended half‐life products in hemophilia: Assay discrepancies for factor VIII and IX in pre‐ and postinfusion samples
BACKGROUND: Monitoring hemophilia treatment with extended half‐life products is challenging for coagulation laboratories since factor assays may show substantial differences between results obtained with the one‐stage assay (OSA) and the chromogenic substrate assay (CSA). OBJECTIVES: The aim of this...
Kaydedildi:
| Yayımlandı: | Res Pract Thromb Haemost |
|---|---|
| Asıl Yazarlar: | , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7590307/ https://ncbi.nlm.nih.gov/pubmed/33134777 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12421 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|